The short version of pentapeptide fits in a sentence. The long version — which is the one that helps — is below.
Reviewed 2026-04-18. Anything still debated is marked as such rather than presented as settled.
Published animal and early human work describes growth hormone release that is separated from comparable rises in adrenocorticotropic hormone and cortisol. Prolactin changes are reported as small in the same studies. Selectivity is attributed to binding at the ghrelin receptor and to the downstream signaling that follows, rather than to differences in how quickly the peptide is cleared. Authors commonly label the compound selective rather than potent, because the same mass produces a smaller growth hormone response than some older secretagogues tested in parallel. Whether that profile holds across species and routes of administration remains an open question.
Human data remain limited and come mainly from small, short-term studies conducted decades ago. The peptide has not received approval as a medicine from major regulators, so current availability is largely as a research chemical. Reported effects on growth hormone pulsatility, appetite, and body composition should be read as preliminary, since few independent groups have replicated the original findings. Analytical characterization of research-grade material varies between suppliers, which complicates comparison across studies. Regulatory status also differs by country, and some jurisdictions classify it as a prescription-only or otherwise restricted item.
Ipamorelin is a synthetic pentapeptide that belongs to the growth hormone secretagogue class. It acts as an agonist at the ghrelin receptor, also called the growth hormone secretagogue receptor type 1a. The compound was designed in the 1990s during a search for agents that release growth hormone with fewer off-target hormonal effects than earlier secretagogues. It appears in the research literature under several sequence-based names. Material supplied for laboratory work is normally a lyophilized solid, and it is not marketed as an approved therapeutic in major jurisdictions.
Published discussion of this compound is uneven. Some references describe it as a tool for probing growth hormone regulation, while others focus on analytical characterization or on comparisons with related secretagogues. Statements about selectivity, half-life and potency often trace back to a small number of original reports that later authors cite secondhand. Readers evaluating a claim should therefore check whether a figure reflects a direct measurement or a repeated citation, and whether the underlying study was conducted in animals, in isolated cells or in human volunteers.
Identity and purity assessment for a research peptide of this kind typically combines reversed-phase high-performance liquid chromatography with mass spectrometry. The chromatographic run separates related impurities and yields a purity percentage, while electrospray ionization or matrix-assisted laser desorption mass spectrometry confirms the expected molecular mass. Amino acid analysis or tandem mass spectrometry sequencing can add confidence when material is intended for quantitative work. Laboratories differ in how they calculate and report purity, so figures from different sources are not always directly comparable.
| Property | Value | Notes |
|---|---|---|
| Molecular formula | C38H49N9O5 | Value for the free base |
| Molar mass | 711.9 g/mol | Calculated from the formula |
| Appearance | White to off-white powder | Typical lyophilized form |
| Mechanism class | Ghrelin receptor agonist | Also described as a secretagogue |
| Half-life | About 2 hours | Reported for human circulation |
Quality claims for research peptides vary widely across suppliers. A certificate of analysis should list purity by chromatography, the mass found by spectrometry, and the analytical conditions used. Independent testing at a third-party laboratory is a common way to check identity and purity, because documents alone cannot confirm what is inside a vial. Purity figures describe the proportion of the target peptide among detected species, and they say nothing about biological activity or sterility.
Lyophilized ipamorelin powder is the form usually supplied for laboratory work. Kept dry, protected from light, and held at minus 20 degrees Celsius or below, it remains stable for extended periods, often measured in years. Once dissolved, the peptide degrades faster through hydrolysis, oxidation, and deamidation, so solutions are typically refrigerated and used within weeks. Repeated freeze-thaw cycles and exposure to alkaline conditions accelerate loss of the parent compound.
Structural features distinguish the molecule from earlier secretagogues. An alpha-aminoisobutyric acid residue near the N-terminus and a D-naphthylalanine substitution increase receptor affinity, while C-terminal amidation improves resistance to exopeptidases. These modifications are associated with reduced stimulation of appetite and of the hypothalamic-pituitary-adrenal axis compared with hexarelin or growth hormone releasing peptide-6. Whether the same profile applies at every dose level studied is a matter of ongoing investigation rather than settled consensus.
Ipamorelin is a synthetic pentapeptide that acts as an agonist at the ghrelin receptor, also called the growth hormone secretagogue receptor type 1a. Its sequence incorporates non-natural residues, which slows enzymatic breakdown relative to short native peptides. In laboratory and early clinical work the compound is described as a selective growth hormone secretagogue because it raises growth hormone with comparatively little effect on other pituitary outputs. The degree to which that selectivity holds across species and dosing regimens remains an open question in the published literature.
Signal transduction begins when the peptide binds GHSR-1a on pituitary somatotrophs. The receptor couples to Gq/11 proteins, activating phospholipase C, which cleaves phosphatidylinositol bisphosphate into inositol trisphosphate and diacylglycerol. Inositol trisphosphate releases calcium from intracellular stores, and the resulting rise in cytosolic calcium drives growth hormone vesicle fusion. Concurrent Gs coupling and cyclic AMP elevation have also been reported, and the relative contribution of each arm to the overall secretory response is not fully settled.
Selectivity distinguishes ipamorelin from first-generation secretagogues such as GHRP-6. At doses that reliably raise growth hormone, it shows little stimulation of adrenocorticotropic hormone or cortisol release in animal models, and it does not markedly raise prolactin or appetite. Binding at GHS-R1a on pituitary somatotrophs triggers calcium influx and pulsatile growth hormone secretion. Because the compound mimics the natural ghrelin signal, the release pattern tends to follow the body's own rhythm rather than producing a sustained elevation.
Most published work on ipamorelin comes from rodent studies and small early-phase human trials. Subcutaneous and intravenous routes have been used, while oral delivery is limited by poor absorption and rapid breakdown in the gut. The reported plasma half-life is short, on the order of two hours, and varies with species and assay method. Whether chronic use produces meaningful clinical benefit remains unresolved, and long-term safety data in humans are sparse. No major regulatory agency has approved the compound as a therapeutic drug.
Ipamorelin is a synthetic pentapeptide that belongs to the growth hormone secretagogue family. Its sequence is Aib-His-D-2-Nal-D-Phe-Lys-NH2, incorporating two non-natural residues that resist enzymatic breakdown. Researchers at Novo Nordisk described the compound in the 1990s while searching for agents that release growth hormone with fewer side effects than earlier secretagogues. The molecule acts as an agonist at the ghrelin receptor, also called GHS-R1a, which is expressed in the pituitary and in several peripheral tissues.
In the scientific literature, ipamorelin appears mainly in preclinical studies, receptor binding assays, and reviews of growth hormone secretagogues. Authors often discuss its selectivity profile alongside limitations such as small sample sizes, short study durations, and differences between species. Some papers examine pharmacokinetics and clearance, but human data are limited and not sufficient to define general clinical effects. Regulatory discussion treats the compound as an investigational or research substance rather than an approved therapy in most jurisdictions. Open questions include oral bioavailability, long-term endocrine effects, and whether selectivity observed in animals persists in humans.
Research peptides such as ipamorelin are commonly supplied as lyophilized powder and characterized by analytical certificates. Reversed-phase high-performance liquid chromatography is used to estimate purity by ultraviolet absorbance, while mass spectrometry confirms molecular identity and detects sequence-related impurities. Counterion content, water content, and residual synthesis reagents can affect the reported mass balance. A certificate of analysis may list a purity percentage, but that number depends on the analytical method and the definition of impurity peaks. Independent verification is often recommended because research supply chains vary in quality control practices.
=== Light utility vehicles === Austin Champ Land Rover series - primary light utility vehicle throughout the Cold War Land Rover 1/2 ton Lightweight - late 1960s onwards Land Rover 101 Forward Control - Gun tractor and ambulance versions Land Rover Defender - mid-1980s onwards
Professor John Joseph Murray, Professor of Child Dental Health, University of Newcastle. For services to Dental Health. Raymond Godfrey Owen, . For public service in Wales, especially to the Police. George Hubbard Makgill, The Viscount of Oxfuird, For political service. David John Parker, Consultant Cardiac Surgeon, St George's Hospital, London. For services to Medicine. Roderick Sayers Paul, lately Chairman, British Water. For services to the Water Industry and to Export. Professor John Pitkeathly Ian Percy, Chairman, Accounts Commission for Scotland. For services to Accounting and to Local Authorities. Rupert Perry, President and Chief Executive Officer, EMI Europe. For services to the Recording Industry. Anna Bridget Plowden. For conservation services to Museums. Christopher Bernard Poole. For political service. Andrew Popat. For political service. David Edwin Potter, Chairman and Chief Executive, Psion plc. For services to the Manufacturing Industry. Bernard Albert Price, County Clerk and Chief Executive, Staffordshire County Council. For services to Local Government. Colonel John Richard George Putnam, . For services to the Territorial Auxiliary and Volunteer Reserve Association in South East England. John Anthony Ransford, lately Honorary Secretary, Association of Directors of Social Services. For services to Social Work. Steven Geoffrey Redgrave, . For services to Rowing. Timothy John Rix. For services to Publishing. Dermot James Roaf. For political and public service. James Donald Robson, , Leader, Durham County Council. For services to Local Government.
to bring historians together and provide a forum for the exchange of views between them; to give a national direction to objective and scientific writing of history and to have rational presentation and interpretation of history; to promote, accelerate and coordinate research in history with special emphasis on areas that have not received adequate attention so far; to promote and coordinate a balanced distribution of research effort over different areas; and to elicit support and recognition for historical research from all concerned and ensure the necessary dissemination and use of results.
=== Apple cultivation === The apple industry is a significant source of employment in Jammu and Kashmir, generating the highest number of jobs. It provides approximately 400-man-days of work per year per hectare of orchards, supporting a workforce of 3.5 million people. Moreover, it contributes approximately 10% to the Gross State Domestic Product (GSDP). In the year 2020–2021, the apple production in Kashmir was reported to be 1,695,000.00 metric tonnes, while in the Jammu Division, it stood at 24,415.69 metric tonnes. The combined apple production for the entire Union Territory of Jammu and Kashmir amounted to 1,719,415.69 metric tonnes. Notably, the Kashmir Valley is the primary contributor to these numbers, accounting for 75% of India's total apple production and exporting around 1.8 million metric tonnes of apples annually.
=== Agar plate method === Variations are seen in the media used for inoculation. Many studies use media with 1 to 2 mg/L of imipenem. However, bacteria that produce OXA-48 or OXA-181 result in low-level resistance, which cannot be detected efficiently due to the high concentration. Therefore, more recent screening media use broth containing 0.5–1 mg/L imipenem or 0.5 mg/L ertapenem. The downsides to this approach include the delay of results from the inoculation and the inability to identify the type of carbapenemase.
Sources: en.wikipedia.org
==== Private ==== Campbell University Norman Adrian Wiggins School of Law (Baptist) Meredith College (Baptist) Montreat College's School of Professional and Adult Studies (Presbyterian) William Peace University (Presbyterian) Shaw University (Baptist) Skema Business School, the first French Business School to open a campus in the US St. Augustine's University (Episcopal)
== Regulation == Among the lipid-binding actin regulatory proteins, gelsolin (like cofilin) preferentially binds polyphosphoinositide (PPI). The binding sequences in gelsolin closely resemble the motifs in the other PPI-binding proteins. Gelsolin's activity is stimulated by calcium ions (Ca2+). Although the protein retains its overall structural integrity in both activated and deactivated states, the S6 helical tail moves like a latch depending on the concentration of calcium ions. The C-terminal end detects the calcium concentration within the cell. When there is no Ca2+ present, the tail of S6 shields the actin-binding sites on one of S2's helices. When a calcium ion attaches to the S6 tail, however, it straightens, exposing the S2 actin-binding sites. The N-terminal is directly involved in the severing of actin. S2 and S3 bind to the actin before the binding of S1 severs actin-actin bonds and caps the barbed end. Gelsolin can be inhibited by a local rise in the concentration of phosphatidylinositol (4,5)-bisphosphate (PIP2), a PPI. This is a two step process. Firstly, (PIP2) binds to S2 and S3, inhibiting gelsolin from actin side binding. Then, (PIP2) binds to gelsolin's S1, preventing gelsolin from severing actin, although (PIP2) does not bind directly to gelsolin's actin-binding site. Gelsolin's severing of actin, in contrast to the severing of microtubules by katanin, does not require any extra energy input.
=== Prostate cancer === In males aged 55 years old and over finasteride decreases the risk of low-grade prostate cancer but may increase the risk of high-grade prostate cancer and has no effect on overall survival. A 2010 review found a 25% reduction in the risk of prostate cancer with 5α-reductase inhibitors. A follow-up study of the Medicare claims of participants in a 10-year Prostate Cancer Prevention Trial suggests the reduction in prostate cancer is maintained even after discontinuation of treatment. However, 5α-reductase inhibitors have been found to increase the risk of developing certain rare but aggressive forms of prostate cancer (27% risk increase), although not all studies have observed this. No impact of 5-α-reductase inhibitor on survival has been found in people with prostate cancer.
=== Pakistan Reinsurance Company === Pakistan Reinsurance Company Limited (PRCL) is a public sector company under the administrative control of the Ministry of Commerce is the sole reinsurance organization operating in Pakistan. Formerly called the Pakistan Insurance Corporation, Pakistan Reinsurance Company Limited was established in 1952.
German is the official and predominantly spoken language in Germany. It is one of 24 official and working languages of the European Union, and one of the three procedural languages of the European Commission, alongside English and French. German is the most widely spoken first language in the European Union, with around 100 million native speakers. Recognised native minority languages in Germany are Danish, Low German, Low Rhenish, Sorbian, Romani, North Frisian and Saterland Frisian; they are officially protected by the European Charter for Regional or Minority Languages. The most used immigrant languages are Turkish, Arabic, Kurdish, Polish, Italian, Greek, Spanish, Serbo-Croatian, Bulgarian and other Balkan languages, as well as Russian. Germans are typically multilingual: 74% of German citizens claim to be able to communicate in at least one foreign language and 35% in at least two.
Sources: en.wikipedia.org
Cardiology Clinical genetics Clinical pharmacology Endocrinology Gastroenterology and hepatology General medicine Geriatric medicine Haemotology Immunology and allergy Infectious diseases Medical oncology Nephrology Neurology Nuclear medicine Respiratory and sleep medicine Rheumatology
=== Hydrodynamic injection === For loading the analytes, the capillary is firstly placed into sample vial. Then there are different ways for hydrodynamic injection: it can be applied positive pressure to inlet, negative pressure to outlet or the sample inlet can be raised in relation to capillary outlet. This technique is able to provide robust and reproducible injected sample amount in comparison to electrokinetic injection and injection RSD value are usually below 2 %. Injected volume and reproducibility of the sample usually depends on injection time, sample height displacement and the pressure applied to the sample. For example, it has been found that using higher pressure and lower injection time leads to reducing of the RSD for peak areas and migration times. One of the main advantages of hydrodynamic injection is also that it is unbiased to molecules with high or low electrophoretic mobility. To increase throughput of CE–MS analysis hydrodynamic multisegment injection technique was created. In this case several samples are loaded hydrodynamically to the separation capillary before the analysis and each sample segment is placed between background electrolyte spacers.
== Chemical properties == Bismuth subcitrate potassium is a salt of bismuth (Bi3+), potassium (K+) and citrate (C6H4O4−7) in a molar ratio of about 1:5:2, with 3 moles of water. It contains about 25.6% (mass percent) bismuth, which is the active moiety, and 22.9% potassium. Other sources give somewhat different ratios of the constituents.
=== Statistics === In 2022, the sector with the highest number of companies registered in Denmark is Finance, Insurance, and Real Estate with 204,853 companies followed by Services and Retail Trade with 204,050 and 30,563 companies respectively.
Two-dimensional chromatography is a type of chromatographic technique in which the injected sample is separated by passing through two different separation stages. Two different chromatographic columns are connected in sequence, and the effluent from the first system is transferred onto the second column. Typically the second column has a different separation mechanism, so that bands that are poorly resolved from the first column may be completely separated in the second column. (For instance, a C18 reversed-phase chromatography column may be followed by a phenyl column.) Alternately, the two columns might run at different temperatures. During the second stage of separation the rate at which the separation occurs must be faster than the first stage, since there is still only a single detector. The plane surface is amenable to sequential development in two directions using two different solvents.
Sources: en.wikipedia.org
It has not been approved as a therapeutic by major regulators, and the human trial record is small and dated. Material available today is mostly sold as a research chemical for laboratory use. Approval and restriction status varies by country.
It binds the ghrelin receptor, known as the growth hormone secretagogue receptor type 1a. Activation of that receptor triggers signaling that leads to growth hormone release. Selectivity for growth hormone over cortisol and prolactin is the property most often cited for this compound.
Published estimates place the circulating half-life at roughly two hours in humans. Clearance involves peptidase activity and renal handling. Because the peptide is short-lived, release patterns after administration are usually described as pulsatile rather than sustained.
Reversed-phase liquid chromatography is standard for purity, and mass spectrometry is standard for identity. Amino acid analysis is used when quantitative composition matters. No single technique answers every question, so laboratories usually combine two or three.